InhaleRx (ASX:IRX) 3-Year EBITDA Growth Rate : 12.60% (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is InhaleRx 3-Year EBITDA Growth Rate?

InhaleRx's EBITDA per Share for the six months ended in Jun. 2023 was A$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 12.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 21.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of InhaleRx was 33.70% per year. The lowest was 12.60% per year. And the median was 26.10% per year.

Competitive Comparison of InhaleRx's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, InhaleRx's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InhaleRx's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InhaleRx's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where InhaleRx's 3-Year EBITDA Growth Rate falls into.

InhaleRx 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

InhaleRx (ASX:IRX) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

InhaleRx 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of InhaleRx's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

InhaleRx (ASX:IRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InhaleRx Ltd (ASX:IRX) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

126 Phillip Street, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.inhalerx.com.au

InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.

InhaleRx (ASX:IRX) Headlines

No Headlines